Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
$0.34
+4.9%
$0.32
$0.25
$0.50
$30.34M1.45883,070 shs214,616 shs
UAV
AdvisorShares Drone Technology ETF
$22.81
-0.9%
$22.81
$19.31
$25.86
$684K1.3236 shs100 shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
-7.07%+5.56%+12.87%+19.16%+34,199,900.00%
UAV
AdvisorShares Drone Technology ETF
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
1.6254 of 5 stars
3.50.00.00.01.61.70.0
UAV
AdvisorShares Drone Technology ETF
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
3.00
Buy$3.881,033.04% Upside
UAV
AdvisorShares Drone Technology ETF
2.79
Moderate Buy$22.81N/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
$1.27M21.44N/AN/A$0.08 per share4.28
UAV
AdvisorShares Drone Technology ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
-$13M-$0.08N/AN/AN/A-714.16%-122.44%-88.40%N/A
UAV
AdvisorShares Drone Technology ETF
N/AN/A7.92N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
N/AN/AN/AN/AN/A
UAV
AdvisorShares Drone Technology ETF
$0.903.95%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
0.02
1.15
0.98
UAV
AdvisorShares Drone Technology ETF
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
3.87%
UAV
AdvisorShares Drone Technology ETF
N/A

Insider Ownership

CompanyInsider Ownership
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
31.48%
UAV
AdvisorShares Drone Technology ETF
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
6179.69 million54.60 millionN/A
UAV
AdvisorShares Drone Technology ETF
N/A30,000N/ANot Optionable

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

IGC Pharma stock logo

IGC Pharma NYSEMKT:IGC

$0.34 +0.02 (+4.88%)
Closing price 07/15/2025 03:58 PM Eastern
Extended Trading
$0.34 -0.01 (-1.75%)
As of 07/15/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.

AdvisorShares Drone Technology ETF NYSEARCA:UAV

$22.81 -0.21 (-0.91%)
As of 06/23/2023

The AdvisorShares Drone Technology ETF (UAV) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund of US-listed companies involved in manufacturing and development of drones and other drone-related technologies. UAV was launched on Apr 27, 2022 and is managed by AdvisorShares.